Cargando…
ERK1/2-Dependent Phosphorylation of GABA(B1)(S867/T872), Controlled by CaMKIIβ, Is Required for GABA(B) Receptor Degradation under Physiological and Pathological Conditions
GABA(B) receptor-mediated inhibition is indispensable for maintaining a healthy neuronal excitation/inhibition balance. Many neurological diseases are associated with a disturbed excitation/inhibition balance and downregulation of GABA(B) receptors due to enhanced sorting of the receptors to lysosom...
Autores principales: | Bhat, Musadiq A., Grampp, Thomas, Benke, Dietmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488028/ https://www.ncbi.nlm.nih.gov/pubmed/37686242 http://dx.doi.org/10.3390/ijms241713436 |
Ejemplares similares
-
Ca(2+)/Calmodulin-Dependent Protein Kinase II (CaMKII) β-Dependent Phosphorylation of GABA(B1) Triggers Lysosomal Degradation of GABA(B) Receptors via Mind Bomb-2 (MIB2)-Mediated Lys-63-Linked Ubiquitination
por: Zemoura, Khaled, et al.
Publicado: (2018) -
Targeting the interaction of GABA(B) receptors with CaMKII with an interfering peptide restores receptor expression after cerebral ischemia and inhibits progressive neuronal death in mouse brain cells and slices
por: Balakrishnan, Karthik, et al.
Publicado: (2022) -
The CaMKII‐dependent phosphorylation of GABA(B)
receptors in the nucleus accumbens was involved in cocaine‐induced behavioral sensitization in rats
por: Lu, Ming F., et al.
Publicado: (2023) -
Restoration of GABA(B) receptor expression in cerebral ischemia: a promising novel neuroprotective strategy
por: Bhat, Musadiq A., et al.
Publicado: (2023) -
BHF177 Suppresses Diabetic Neuropathic Pain by Blocking PKC/CaMKII/ERK1/2/CREB Signaling Pathway through Activating GABA(B) Receptor
por: Liu, Boyu, et al.
Publicado: (2022)